Aromasin at a Glance
Aromasin 25mg is a pharmaceutical-grade exemestane formulation manufactured by Saxon Pharmaceuticals for laboratory research applications. Exemestane is a steroidal aromatase inhibitor belonging to the third generation of selective enzyme modulators. This compound demonstrates irreversible binding characteristics to the aromatase enzyme complex, distinguishing it from reversible competitive inhibitors in biochemical pathway studies. Research institutions investigating endocrine signalling cascades utilise this formulation to examine estrogen biosynthesis suppression mechanisms in controlled laboratory environments. The 25mg tablet format provides researchers with precise dosing capabilities essential for maintaining consistency across experimental protocols.
Laboratory Applications
Research scientists examine Aromasin in studies investigating hormonal regulatory mechanisms and aromatase enzyme function. Laboratory investigations focus on understanding how selective enzyme inhibition affects downstream metabolic pathways and cellular signalling networks. Preclinical research models utilise exemestane to study estrogen-dependent processes in various tissue types, particularly in endocrinology and reproductive biology research. Academic institutions conducting Stroid UK Shop analyse this compound’s irreversible inhibition characteristics compared to other aromatase modulators. Researchers exploring aromatase inhibitor mechanisms investigate its unique steroidal structure and binding kinetics. Studies examining endocrine disruption often incorporate exemestane as a reference compound alongside investigations into selective receptor modulators and peptide-based regulators to understand comprehensive hormonal pathway interactions.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Exemestane |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.4 g/mol |
| Tablet Strength | 25mg per tablet |
| Package Count | 50 tablets |
| Manufacturer | Saxon Pharmaceuticals |
| Storage Requirements | Room temperature, dry environment |
Research Compliance
This exemestane formulation is supplied exclusively for in-vitro laboratory research and analytical applications. Aromasin 25mg tablets are not intended for human consumption, clinical use, or therapeutic applications. Research institutions must maintain appropriate laboratory protocols and safety measures when handling this aromatase inhibitor compound. All investigations should comply with institutional guidelines governing biochemical research materials and experimental procedures.
